Literature DB >> 10837941

Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery.

S L Meeks1, J M Buatti, K D Foote, W A Friedman, F J Bova.   

Abstract

PURPOSE: Estimations of complications from stereotactic radiosurgery usually rely simply on dose-volume or dose-diameter isoeffect curves. Due to the sparse clinical data available, these curves have typically not considered the target location in the brain, target histology, or treatment plan conformality as parameters in the calculation. In this study, a predictive model was generated to estimate the probability of cranial neuropathies as a result of acoustic schwannoma radiosurgery. METHODS AND MATERIALS: The dose-volume histogram reduction scheme was used to calculate the normal tissue complication probability (NTCP) from brainstem dose-volume histograms. The model's fitting parameters were optimized to provide the best fit to the observed complication data for acoustic neuroma patients treated with stereotactic radiosurgery at the University of Florida. The calculation was then applied to the remainder of the patients in the database.
RESULTS: The best fit to our clinical data was obtained using n = 0.04, m = 0.15, and alpha/beta = 2.1 Gy(-1). Although the fitting parameter m is relatively consistent with ranges found in the literature, both the volume parameter, n, and alpha/beta are much smaller than the values quoted in the literature. The fit to our clinical data indicates that brainstem, or possibly a specific portion of the brainstem, is more radiosensitive than the parameters in the literature indicate, and that there is very little volume effect; in other words, irradiation of a small fraction of the brainstem yields NTCPs that are nearly as high as those calculated for entire volume irradiation. These new fitting parameters are specific to acoustic neuroma radiosurgery, and the small volume effect that we observe may be an artifact of the fixed relationship of acoustic tumors to specific regions of the brainstem. Applying the model to our patient database, we calculate an average NTCP of 7.2% for patients who had no cranial nerve complications, and the average NTCP for was 66% for patients who sustained a cranial neuropathy. For the entire patient population, the actual percentage of patients suffering either facial or trigeminal neuropathy was 14.7%, whereas the calculated average NTCP was 14.8%. DISCUSSION: NTCP calculations using brainstem dose-volume histograms can be used to estimate the rate of cranial neuropathies from acoustic neuroma radiosurgery. More clinical data and further study will lead to refinement of the model with time.

Entities:  

Mesh:

Year:  2000        PMID: 10837941     DOI: 10.1016/s0360-3016(00)00493-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Radiation associated brainstem injury.

Authors:  Charles Mayo; Ellen Yorke; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Target delineation and optimal radiosurgical dose for pituitary tumors.

Authors:  Giuseppe Minniti; Mattia Falchetto Osti; Maximillian Niyazi
Journal:  Radiat Oncol       Date:  2016-10-11       Impact factor: 3.481

3.  [Stereotactic radiosurgery and fractionated stereotactic radiotherapy of acoustic neuromas].

Authors:  F Unger; K Dominikus; K Haselsberger
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

Review 4.  Management of nonfunctioning pituitary tumors: radiotherapy.

Authors:  Giuseppe Minniti; John Flickinger; Barbara Tolu; Sergio Paolini
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

5.  Boron distribution in the normal rat brain after intravenous injection of boronophenylalanine-fructose.

Authors:  Yasushi Shibata
Journal:  J Neurooncol       Date:  2007-11-20       Impact factor: 4.130

6.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

7.  Spatial Agreement of Brainstem Dose Distributions Depending on Biological Model in Proton Therapy for Pediatric Brain Tumors.

Authors:  Lars Fredrik Fjæra; Daniel J Indelicato; Kristian S Ytre-Hauge; Ludvig P Muren; Yasmin Lassen-Ramshad; Laura Toussaint; Olav Dahl; Camilla H Stokkevåg
Journal:  Adv Radiat Oncol       Date:  2020-08-28

8.  The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy.

Authors:  Helge Henjum; Tordis J Dahle; Lars Fredrik Fjæra; Eivind Rørvik; Sara Pilskog; Camilla H Stokkevåg; Andrea Mairani; Kristian S Ytre-Hauge
Journal:  Adv Radiat Oncol       Date:  2021-08-17

9.  Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.

Authors:  Xigang Fan; Yecai Huang; Peng Xu; Yanmei Min; Jie Li; Mei Feng; Guohui Xu; Jinyi Lang
Journal:  BMC Cancer       Date:  2022-02-17       Impact factor: 4.430

10.  CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas.

Authors:  Yoshihiko Manabe; Taro Murai; Hiroyuki Ogino; Takeshi Tamura; Michio Iwabuchi; Yoshimasa Mori; Hiromitsu Iwata; Hirochika Suzuki; Yuta Shibamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-10-12       Impact factor: 1.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.